share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director BLAYLOCK RONALD E

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director BLAYLOCK RONALD E

辉瑞 | 4:持股变动声明-董事 BLAYLOCK RONALD E
美股sec公告 ·  04/26 13:24
Moomoo AI 已提取核心信息
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
辉瑞公司 [PFE] 的申报人罗纳德·布莱洛克于2024年4月25日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。为布莱洛克先生提供的地址是纽约州纽约哈德逊大道东66号,邮编10001-2192。提供的资料中没有具体说明布莱洛克先生与辉瑞公司的关系。
辉瑞公司 [PFE] 的申报人罗纳德·布莱洛克于2024年4月25日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。为布莱洛克先生提供的地址是纽约州纽约哈德逊大道东66号,邮编10001-2192。提供的资料中没有具体说明布莱洛克先生与辉瑞公司的关系。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息